Government officials told PTI that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after a thorough evaluation based on the recommendations of the Subject Expert Committee on -19.
from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/31g34Ol
Post Top Ad
Your Ad Spot
Monday, August 3, 2020
Home
India
India News | Latest News Headlines & Live Updates from India - Times of India
COVID-19: DCGI nod to Serum Institute of India for phase 2 and 3 human clinical trials of Oxford vaccine candidate
COVID-19: DCGI nod to Serum Institute of India for phase 2 and 3 human clinical trials of Oxford vaccine candidate
Tags
# India
# India News | Latest News Headlines & Live Updates from India - Times of India
About Hindustan News
Templatesyard is a blogger resources site is a provider of high quality blogger template with premium looking layout and robust design. The main mission of templatesyard is to provide the best quality blogger templates which are professionally designed and perfectlly seo optimized to deliver best result for your blog.
India News | Latest News Headlines & Live Updates from India - Times of India
Subscribe to:
Post Comments (Atom)
Post Top Ad
Your Ad Spot
No comments:
Post a Comment